As an initial attempt, we focused on the ANGPTL1 and SOCS3 genes to investigate the feasibility of developing a circNAs strategy to target apoptosis and inhibit the malignant progression of HCC cells. The gene discussed is ANGPTL1; the disease is hepatocellular carcinoma.